1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients

Article

Abstract: Conventional treatment of non-small cell lung cancer (NSCLC) has apparently reached a plateau of eff

Palabras claves:

Anti-idiotype antibody, Cancer Vaccines, Clinical study, immunotherapy

Autores:

Aguirre F., Alfonso S., Alonso D.F., Barroso M.C., Carmen Elena Viada, De La Torre A.V., Díaz R.M., Gabri M.R., Gómez R., Hernández A.M., Macías A.E., Pérez K., Pérez R., Rodríguez J., Santiesteban E.R., Suárez E., Toledo D., Vázquez A.M.

Fuentes:

scopus